1-2 of 2
Andy P. Haynes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Response Rate to DLI Based Strategies for the Treatment of Refractory Disease/Relapse Following Allogeneic HSCT for Lymphoproliferative Disease.

Nigel H. Russell, MD, Jenny L. Byrne, PhD, Emma P. Das-Gupta, MD, Michelle Gilyead, BSc, Andy P. Haynes, MD
Journal: Blood
Blood (2004) 104 (11): 1653.
https://doi.org/10.1182/blood.V104.11.1653.1653
Published: 2004
Journal Articles

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Clinical Trials & Observations
Andy C. Rawstron, Ben Kennedy, Paul A. S. Evans, Faith E. Davies, Stephen J. Richards, Andy P. Haynes, Nigel H. Russell, Geoff Hale, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen
Journal: Blood
Blood (2001) 98 (1): 29–35.
https://doi.org/10.1182/blood.V98.1.29
Published: 2001